Search results
Results from the 24/7 Vacations Content Network
On April 9, 2019 Alcon becomes a separately traded company. Novartis and Alcon are now positioned to capitalize on significant growth opportunities and focus resources on their respective businesses and strategic priorities.
Exactly eight years into its full ownership of Alcon, Novartis will officially say goodbye to the eye care business on April 9. The new Alcon shares will be listed on the Swiss Exchange and the...
Alcon becomes an independent, publicly-traded company, after spinning off from Novartis. Alcon offers the widest array of contact lenses and surgical and ocular health products in the industry
Geneva, April 9, 2019 – Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its debut as an independent, publicly traded company and the completion of its separation from Novartis.
The successful execution of the Alcon spin-off allows Novartis to fully focus its capital allocation and management attention on medicines. The spin-off gives Novartis a financial profile closer to its pharmaceutical industry peers, including higher group margins.
Basel, June 29, 2018 - Novartis today announced its intention to spinoff Alcon, its eye care division, into a separately-traded standalone company. The planned spinoff would enable Novartis and Alcon to focus fully on their respective growth strategies.
Alcon, a legacy from former Novartis boss Daniel Vasella's empire building, has been problematic since Novartis bought it for $52 billion in 2011, expanding into implantable lenses for cataract...
Novartis announces that it will spin-off its ophthalmology division, Alcon, into a separately-traded standalone company in order to focus on its legacy pharmaceuticals business.
Basel, January 4, 2010 - Novartis intends to gain full ownership of Alcon Inc. (NYSE: ACL) by first completing the April 2008 agreement with Nestlé S.A. to acquire a 77% majority stake in a ...
With the achievement of the 77% majority ownership, Novartis and Alcon will be able to create greater value together for all stakeholders through collaborations that would benefit both...